“How is it going to help?”: Exploring Black breast cancer patients’ questions about biomarker testing to predict chemotherapy-induced peripheral neuropathy

OBJECTIVE: Many Black breast cancer patients experience chemotherapy-induced peripheral neuropathy (CIPN). Our study assessed Black breast cancer patients’ questions about a biomarker test that can predict likelihood of CIPN. METHODS: Nineteen Black women who were previous/current breast cancer pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Head, Katharine J., Hayes, Lisa R., Miller, Nadia E., Shakil, Safia, Bales, Casey L., Schneider, Bryan P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles from Special issue on Communication in Genomic and Precision Medicine; Edited by Gemme Campbell-Salome
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10194344/
https://www.ncbi.nlm.nih.gov/pubmed/37214510
http://dx.doi.org/10.1016/j.pecinn.2022.100118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10194344/
https://www.ncbi.nlm.nih.gov/pubmed/37214510
http://dx.doi.org/10.1016/j.pecinn.2022.100118

Ejemplares similares